Aberrant hypomethylation and overexpression of the eyes absent homologue 2 suppresses tumor cell growth of human lung adenocarcinoma cells

Oncology Reports

Volumn 34, Issue 5, 2015, Pages 2333-2342

  Gao, Tangxin ^a,b   Zheng, Shangyong ^a,b   Li, Qian ^b   Ran, Pengzhan ^a   Sun, Lijuan ^a   Yuan, Yuncang ^b   Xiao, Chunjie ^a,b  

^a YUNNAN UNIVERSITY   (China)

^b Key Laboratory of Molecular Genetics of Human Complicated Diseases Department of Education   (China)

Author keywords

Apoptosis; Eyes absent homologue 2 protein; Invasion; Methylation; Migration; Non small lung cancer; Proliferation

Indexed keywords

ADENOCARCINOMA CELL LINE; ADULT; APOPTOSIS; ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DOWN REGULATION; EYES ABSENT HOMOLOGUE 2 GENE; FEMALE; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG ALVEOLUS EPITHELIUM CELL; MALE; METHYLATION; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; RNA INTERFERENCE; TUMOR SUPPRESSOR GENE; UPREGULATION; 5' UNTRANSLATED REGION; ADENOCARCINOMA; CELL CYCLE CHECKPOINT; CELL MOTION; DNA METHYLATION; ENZYMOLOGY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; LUNG TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; TRANSCRIPTION INITIATION SITE; TUMOR CELL LINE;

5' UNTRANSLATED REGION; EYA2 PROTEIN, HUMAN; NUCLEAR PROTEIN; PROTEIN TYROSINE PHOSPHATASE; SIGNAL PEPTIDE; SMALL INTERFERING RNA;

5' UNTRANSLATED REGIONS; ADENOCARCINOMA; ADULT; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PROTEIN TYROSINE PHOSPHATASES; RNA, SMALL INTERFERING; TRANSCRIPTION INITIATION SITE;

EID: 84941959586     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.4245     Document Type: Article

References (46)

1. Kumar V, Abass KA, Fausto N and Mitchell R: Robbins Basic Pathology. 8th edition, Saunders Elsevier, Philadelphia, PA, 2007.
2. Brambilla E, Travis WD, Colby TV, Corrin B and Shimosato Y: The new World Health Organization classification of lung tumours. Eur Respir J 18: 1059-1068, 2001.
3. Chu XY, Hou XB, Song WA, Xue ZQ, Wang B and Zhang LB: Diagnostic values of SCC, CEA, Cyfra21-1 and NSE for lung cancer in patients with suspicious pulmonary masses: A single center analysis. Cancer Biol Ther 11: 995-1000, 2011.
4. Portela A and Esteller M: Epigenetic modifications and human disease. Nat Biotechnol 28: 1057-1068, 2010.
5. Takai D and Jones PA: Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci USA 99: 3740-3745, 2002.
6. Grønbaek K, Hother C and Jones PA: Epigenetic changes in cancer. APMIS 115: 1039-1059, 2007.
7. Lokk K, Vooder T, Kolde R, Välk K, Võsa U, Roosipuu R, Milani L, Fischer K, Koltsina M, Urgard E, et al: Methylation markers of early-stage non-small cell lung cancer. PLoS One 7: e39813, 2012.
8. Tekpli X, Landvik NE, Anmarkud KH, Skaug V, Haugen A and Zienolddiny S: DNA methylation at promoter regions of interleukin 1B, interleukin 6, and interleukin 8 in non-small cell lung cancer. Cancer Immunol Immunother 62: 337-345, 2013.
9. Sato T, Arai E, Kohno T, Tsuta K, Watanabe S, Soejima K, Betsuyaku T and Kanai Y: DNA methylation profiles at precancerous stages associated with recurrence of lung adenocarcinoma. PLoS One 8: e59444, 2013.
10. Pesta M, Kulda V, Topolcan O, Safranek J, Vrzalova J, Cerny R and Holubec L: Significance of methylation status and the expression of RECK mRNA in lung tissue of patients with NSCLC. Anticancer Res 29: 4535-4539, 2009.
11. Suzuki M, Shiraishi K, Eguchi A, Ikeda K, Mori T, Yoshimoto K, Ohba Y, Yamada T, Ito T, Baba Y, et al: Aberrant methylation of LINE-1, SLIT2, MAL and IGFBP7 in non-small cell lung cancer. Oncol Rep 29: 1308-1314, 2013.
12. Grimminger PP, Maus MK, Schneider PM, Metzger R, Hölscher AH, Sugita H, Danenberg PV, Alakus H and Brabender J: Glutathione S-transferase PI (GST-PI) mRNA expression and DNA methylation is involved in the pathogenesis and prognosis of NSCLC. Lung Cancer 78: 87-91, 2012.
13. Duan H, He Z, Ma J, Zhang B, Sheng Z, Bin P, Cheng J, Niu Y, Dong H, Lin H, et al: Global and MGMT promoter hypomethylation independently associated with genomic instability of lymphocytes in subjects exposed to high-dose polycyclic aromatic hydrocarbon. Arch Toxicol 87: 2013-2022, 2013.
14. Tadjuidje E and Hegde RS: The eyes absent proteins in development and disease. Cell Mol Life Sci 70: 1897-1913, 2013.
15. Huang YT, Heist RS, Chirieac LR, Lin X, Skaug V, Zienolddiny S, Haugen A, Wu MC, Wang Z, Su L, et al: Genome-wide analysis of survival in early-stage non-small-cell lung cancer. J Clin Oncol 27: 2660-2667, 2009.
16. Bierkens M, Krijgsman O, Wilting SM, Bosch L, Jaspers A, Meijer GA, Meijer CJ, Snijders PJ, Ylstra B and Steenbergen RD: Focal aberrations indicate EYA2 and hsa-miR-375 as oncogene and tumor suppressor in cervical carcinogenesis. Genes Chromosomes Cancer 52: 56-68, 2013.
17. Farabaugh SM, Micalizzi DS, Jedlicka P, Zhao R and Ford HL: Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties. Oncogene 31: 552-562, 2012.
18. Zhang L, Yang N, Huang J, Buckanovich RJ, Liang S, Barchetti A, Vezzani C, O'Brien-Jenkins A, Wang J, Ward MR, et al: Transcriptional coactivator Drosophila eyes absent homologue 2 is up-regulated in epithelial ovarian cancer and promotes tumor growth. Cancer Res 65: 925-932, 2005.
19. Yeh PA, Yang WH, Chiang PY, Wang SC, Chang MS and Chang CJ: Drosophila eyes absent is a novel mRNA target of the tristetraprolin (TTP) protein DTIS11. Int J Biol Sci 8: 606-619, 2012.
20. Zou H, Harrington JJ, Shire AM, Rego RL, Wang L, Campbell ME, Oberg AL, Ahlquist DA: Highly methylated genes in colorectal neoplasia: implications for screening. Cancer Epidemiol, Biomarkers Prev 16: 2686-2696, 2007.
21. Vincent A, Hong SM, Hu C, Omura N, Young A, Kim H, Yu J, Knight S, Ayars M, Griffith M, et al: Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growth. Oncotarget 5: 2575-2587, 2014.
22. Jemc J and Rebay I: Identification of transcriptional targets of the dual-function transcription factor/phosphatase eyes absent. Dev Biol 310: 416-429, 2007.
23. J emc J and Rebay I: The eyes absent family of phosphotyrosine phosphatases: Properties and roles in developmental regulation of transcription. Annu Rev Biochem 76: 513-538, 2007.
24. Krishnan N, Jeong DG, Jung SK, Ryu SE, Xiao A, Allis CD, Kim SJ and Tonks NK: Dephosphorylation of the C-terminal tyrosyl residue of the DNA damage-related histone H2A.X is mediated by the protein phosphatase eyes absent. J Biol Chem 284: 16066-16070, 2009.
25. Spackman E and Suarez DL: Type A influenza virus detection and quantitation by real-time RT-PCR. Methods Mol Biol 436: 19-26, 2008.
26. Kobayashi H and Kono T: DNA methylation analysis of germ cells by using bisulfite-based sequencing methods. Methods Mol Biol 825: 223-235, 2012.
27. Becker D, Lutsik P, Ebert P, Bock C, Lengauer T and Walter J: BiQ Analyzer HiMod: An interactive software tool for high-throughput locus-specific analysis of 5-methylcytosine and its oxidized derivatives. Nucleic Acids Res 42 (W1): W501-W507, 2014.
28. Arranz-Valsero I, Soriano-Romaní L, García-Posadas L, Lopez-Garcia A and Diebold Y: IL-6 as a corneal wound healing mediator in an in vitro scratch assay. Exp Eye Res 125: 183-192, 2014.
29. Guo J, Lin P, Zhao X, Zhang J, Wei X, Wang Q and Wang C: Etazolate abrogates the lipopolysaccharide (LPS)-induced downregulation of the cAMP/pCREB/BDNF signaling, neuroinflammatory response and depressive-like behavior in mice. Neuroscience 263: 1-14, 2014.
30. Yang DK, Choi BY, Lee YH, Kim YG, Cho MC, Hong SE, Kim H, Hajjar RJ and Park WJ: Gene profiling during regression of pressure overload-induced cardiac hypertrophy. Physiol Genomics 30: 1-7, 2007.
31. Lee SH, Yang DK, Choi BY, Lee YH, Kim SY, Jeong D, Hajjar RJ and Park WJ: The transcription factor Eya2 prevents pressure overload-induced adverse cardiac remodeling. J Mol Cell Cardiol 46: 596-605, 2009.
32. Lee SH, Kim J, Ryu JY, Lee S, Yang DK, Jeong D, Kim J, Lee SH, Kim JM, Hajjar RJ, et al: Transcription coactivator Eya2 is a critical regulator of physiological hypertrophy. J Mol Cell Cardiol 52: 718-726, 2012.
33. Patrick AN, Cabrera JH, Smith AL, Chen XS, Ford HL and Zhao R: Structure-function analyses of the human SIX1-EYA2 complex reveal insights into metastasis and BOR syndrome. Nat Struct Mol Biol 20: 447-453, 2013.
34. Ohto H, Kamada S, Tago K, Tominaga SI, Ozaki H, Sato S and Kawakami K: Cooperation of six and eya in activation of their target genes through nuclear translocation of Eya. Mol Cell Biol 19: 6815-6824, 1999.
35. Grifone R, Demignon J, Giordani J, Niro C, Souil E, Bertin F, Laclef C, Xu PX and Maire P: Eya1 and Eya2 proteins are required for hypaxial somitic myogenesis in the mouse embryo. Dev Biol 302: 602-616, 2007.
36. Embry AC, Glick JL, Linder ME and Casey PJ: Reciprocal signaling between the transcriptional co-factor Eya2 and specific members of the Galphai family. Mol Pharmacol 66: 1325-1331, 2004.
37. Ali-Khan SE and Hales BF: Novel retinoid targets in the mouse limb during organogenesis. Toxicol Sci 94: 139-152, 2006.
38. Molinari M: Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif 33: 261-274, 2000.
39. Fu J, Xu X, Kang L, Zhou L, Wang S, Lu J, Cheng L, Fan Z, Yuan B, Tian P, et al: miR-30a suppresses breast cancer cell proliferation and migration by targeting Eya2. Biochem Biophys Res Commun 445: 314-319, 2014.
40. Clark SW, Fee BE and Cleveland JL: Misexpression of the eyes absent family triggers the apoptotic program. J Biol Chem 277: 3560-3567, 2002.
41. Matt N, Dupé V, Garnier JM, Dennefeld C, Chambon P, Mark M and Ghyselinck NB: Retinoic acid-dependent eye morphogenesis is orchestrated by neural crest cells. Development 132: 4789-4800, 2005.
42. Li X, Oghi KA, Zhang J, Krones A, Bush KT, Glass CK, Nigam SK, Aggarwal AK, Maas R, Rose DW, et al: Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis. Nature 426: 247-254, 2003.
43. Kohrt D, Crary J, Zimmer M, Patrick AN, Ford HL, Hinds PW and Grossel MJ: CDK6 binds and promotes the degradation of the EYA2 protein. Cell Cycle 13: 62-71, 2014.
44. Bonini NM, Leiserson WM and Benzer S: The eyes absent gene: Genetic control of cell survival and differentiation in the developing Drosophila eye. Cell 72: 379-395, 1993.
45. Pandey RN, Rani R, Yeo EJ, Spencer M, Hu S, Lang RA and Hegde RS: The Eyes Absent phosphatase-transactivator proteins promote proliferation, transformation, migration, and invasion of tumor cells. Oncogene 29: 3715-3722, 2010.
46. Krueger AB, Drasin DJ, Lea WA, Patrick AN, Patnaik S, Backos DS, Matheson CJ, Hu X, Barnaeva E, Holliday MJ, et al: Allosteric inhibitors of the Eya2 phosphatase are selective and inhibit Eya2-mediated cell migration. J Biol Chem 289: 16349-16361, 2014.